RESVERATROL APPEARS TO RESTORE BLOOD-BRAIN BARRIER INTEGRITY IN ALZHEIMER’S DISEASE

Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues. The reduction in neuronal inflammation slowed the cognitive decline of patients, compared to a matching group of placebo-treated patients with the disorder.

 https://gumc.georgetown.edu/news/Resveratrol-Appears-to-Restore-Blood-Brain-Barrier-Integrity-in-Alzheimers-Disease



Comments

Post a Comment

Popular posts from this blog

First New Drug for Liver Cancer in a Decade: Regorafenib

The US Food and Drug Administration (FDA) has expanded the indication for regorafenib ( Stivarga , Bayer) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug sorafenib ( Nexavar , Bayer). Expansion of regorafenib's indication marks the first FDA-approved treatment for a liver cancer in almost a decade! Medscape article: http://www.medscape.com/viewarticle/879216?src=soc_fb_170427_mscpedt_news_onc_livercancer
Read more